Fahs, D., Salloum, D., Nasrallah, M., and Ghazeeri, G., Polycystic ovary syndrome: Pathophysiology and controversies in diagnosis, Diagnostics, 2023, vol. 13, no. 9, p. 1559.
Article CAS PubMed PubMed Central Google Scholar
Marques, P., Skorupskaite, K., Rozario, K.S., Anderson, R.A., and George, J.T., Physiology of GNRH and gonadotropin secretion, Endotext , 2022.
Karkera, S., Agard, E., and Sankova, L., The clinical manifestations of polycystic ovary syndrome (PCOS) and the treatment options, Eur. J. Biol. Med. Sci. Res., 2023, vol. 11, no. 1, pp. 57–91.
Rao, P. and Bhide, P., Controversies in the diagnosis of polycystic ovary syndrome, Ther. Adv. Reprod. Health, 2020, vol. 14, p. 2633494120913032.
Article PubMed PubMed Central Google Scholar
Liew, F.F., Dutta, S., and Sengupta, P., Fertility treatment-induced oxidative stress and reproductive disorders, J. Integr. Sci. Technol., 2024, vol. 12, no. 3, р. 756.
Piri-Gharaghie, T., Polycystic ovary syndrome and genetic factors influencing its development: A review article, Pers. Med. J., 2021, vol. 6, no. 23, pp. 25–29.
Parker, J., O’brien, C., Hawrelak, J., and Gersh, F.L., Polycystic ovary syndrome: An evolutionary adaptation to lifestyle and the environment, Int. J. Environ. Res. Public Health, 2022, vol. 19, no. 3, p. 1336.
Article CAS PubMed PubMed Central Google Scholar
AlHussain, F., AlRuthia, Y., Al-Mandeel, H., Bellahwal, A., Alharbi, F., Almogbel, Y., et al., Metformin improves the depression symptoms of women with polycystic ovary syndrome in a lifestyle modification program, Patient Prefer. Adherence, 2020, pp. 737–746.
Ee, C., Pirotta, S., Mousa, A., Moran, L., and Lim, S., Providing lifestyle advice to women with PCOS: An overview of practical issues affecting success, BMC Endocr. Disord., 2021, vol. 21, p. 234.
Article CAS PubMed PubMed Central Google Scholar
Russell, D.H., The physiological significance of ornithine decarboxylase, in The Physiology of Polyamines, CRC Press, 2021, vol. 1, pp. 255–279.
Kang, B., Wang, X., An, X., Ji, C., Ling, W., Qi, Y., et al., Polyamines in ovarian aging and disease, Int. J. Mol. Sci., 2023, vol. 24, no. 20, p. 15330.
Article CAS PubMed PubMed Central Google Scholar
Yurdagul, A., Jr., Kong, N., Gerlach, B.D., Wang, X., Ampomah, P., Kuriakose, G., et al., ODC (ornithine decarboxylase)-dependent putrescine synthesis maintains MerTK (MER tyrosine-protein kinase) expression to drive resolution, Arterioscler., Thromb., Vasc. Bi-ol., 2021, vol. 41, no. 3, pp. e144–e159.
Mate, N.A., Wadhwa, G., Taliyan, R., and Banerjee, A., Impact of polyamine supplementation on GnRH expression, folliculogenesis, and puberty onset in young mice, Theriogenology, 2024, vol. 229, pp. 202–213.
Article CAS PubMed Google Scholar
Ramil, R.J.D., Assessment on the physicochemical and phytochemical properties, nutritional and heavy metal contents, and antioxidant activities of Hylocereus polyrhizus peel from Northern Philippines, Indian J. Sci. Technol., 2021, vol. 14, p. 2286.
Niepsuj, J., Franik, G., Madej, P., Piwowar, A., and Bizoń, A., Evaluation of pro/antioxidant imbalance in blood of women with polycystic ovary syndrome based on determination of oxidized low-density lipoproteins and ferric reducing ability of plasma values, Biomedicines, 2022, vol. 10, no. 7, p. 1564.
Article CAS PubMed PubMed Central Google Scholar
Benzie, I.F. and Strain, J.J., The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay, Anal. Biochem., 1996, vol. 239, no. 1, pp. 70–76.
Article CAS PubMed Google Scholar
Bhattacharya, K., Saha, I., Sen, D., Bose, C., Chaudhuri, G.R., Dutta, S., et al., Role of anti-Mullerian hormone in polycystic ovary syndrome, Middle East Fertil. Soc. J., 2022, vol. 27, no. 1, p. 32.
Shrikhande, L., Shrikhande, B., and Shrikhande, A., AMH and its clinical implications, J. Obstet. Gynecol. India, 2020, vol. 70, no. 5, pp. 337–341.
Dewailly, D., Barbotin, A.-L., Dumont, A., Catteau-Jonard, S., and Robin, G., Role of anti-Müllerian hormone in the pathogenesis of polycystic ovary syndrome, Front. Endocrinol., 2020, vol. 11, p. 641.
Palmerola, K.L., Montenegro, M., Bustillo, M., Collazo, I., Valdes, Y., and Arora, H., Subclinical inflammation linked to elevated AMH levels and decreased IVF pregnancy rates, Fertil. Steril., 2023, vol. 120, no. 4, p. e246.
Bongrani, A., Plotton, I., Mellouk, N., Ramé, C., Guerif, F., Froment, P., et al., High androgen concentrations in follicular fluid of polycystic ovary syndrome women, Reprod. Biol. Endocrinol., 2022, vol. 20, no. 1, p. 88.
Article CAS PubMed PubMed Central Google Scholar
de las Heras, M. and Calandra, R., Androgen-dependence of ornithine decarboxylase in the rat, J. Reprod. Fertil., 1987, vol. 79, pp. 9–14.
Article CAS PubMed Google Scholar
Rui, H., Brekke, I., Mørkås, L., and Purvis, K., Androgen interaction with the polyamine system of the rat prostate, Andrologia, 1987, vol. 19, no. 2, pp. 134–142.
Article CAS PubMed Google Scholar
Zhou, Z., Chen, H., Chu, L., Zou, Q., Chen, Q., Yang, J., et al., The effects of metformin on anti-Müllerian hormone levels in patients with polycystic ovary syndrome: A systematic review and meta-analysis, J. Ovarian Res., 2023, vol. 16, no. 1, p. 123.
Article CAS PubMed PubMed Central Google Scholar
Mehdinezhad Roshan, M., Sohouli, M.H., Izze da Silva Magalhães, E., and Hekmatdoost, A., Effect of metformin on anti-mullerian hormone levels in women with polycystic ovarian syndrome: A systematic review and meta-regression analysis of randomized controlled trials with, BMC Endocr. Disord., 2024, vol. 24, no. 1, p. 43.
Article CAS PubMed PubMed Central Google Scholar
Ohara, M., Yoshida-Komiya, H., Ono-Okutsu, M., Yamaguchi-Ito, A., Takahashi, T., and Fujimori, K., Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome, Reprod. Biol. Endocrinol., 2021, vol. 19,pp. 77.
Mastnak, L., Herman, R., Ferjan, S., Janež, A., and Jensterle, M., Prolactin in polycystic ovary syndrome: Metabolic effects and therapeutic prospects, Life, 2023, vol. 13, no. 11, p. 2124.
Article CAS PubMed PubMed Central Google Scholar
Davoudi, Z., Araghi, F., Vahedi, M., Mokhtari, N., and Gheisari, M., Prolactin level in polycystic ovary syndrome (PCOS): An approach to the diagnosis and management, Acta Bio Med. Atenei Parmensis, 2021, vol. 92, no. 5.
Goyal, A. and Ganie, M.A., Idiopathic hyperprolactinemia presenting as polycystic ovary syndrome in identical twin sisters: A case report and literature review, Cureus, 2018, vol. 10, no. 7, p. e3004.
Krysiak, R., Kowalcze, K., and Okopień, B., The impact of metformin on prolactin levels in postmenopausal women, J. Clin. Pharm. Ther., 2021, vol. 46, no. 5, pp. 1433–1440.
Article CAS PubMed Google Scholar
Krysiak, R., Kowalcze, K., Szkróbka, W., and Okopień, B., Impaired prolactin-lowering effects of metformin in women with polycystic ovary syndrome, J. Clin. Med., 2023, vol. 12, no. 17, p. 5474.
Article CAS PubMed PubMed Central Google Scholar
Lee, H.J., Jo, H.N., Noh, H.K., Kim, S.H., and Joo, J.K., Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?, Ginekol. Pol., 2023, vol. 94, no. 3, pp. 203–210.
Khan, A.A., Sharma, R., Ata, F., Khalil, S.K., Aldien, A.S., Hasnain, M., et al., Systematic review of the association between thyroid disorders and hyperprolactinemia, Thyroid Res., 2025, vol. 18, no. 1, p. 1.
Article PubMed PubMed Central Google Scholar
Cai, J., Zhang, Y., Wang, Y., Li, S., Wang, L., Zheng, J., et al., High thyroid stimulating hormone level is associated with hyperandrogenism in euthyroid polycystic ovary syndrome (PCOS) women, independent of age, BMI, and thyroid autoimmunity: A cross-sectional analysis, Front. Endocrinol., 2019, vol. 10, p. 222.
Cannarella, R., Condorelli, R., Barbagallo, F., Aversa, A., Calogero, A., and La Vignera, S., TSH lowering effects of metformin: A possible mechanism of action, J. Endocrinol. Invest., 2021, vol. 44, pp. 1547–1550.
Article CAS PubMed Google Scholar
Amirabadizadeh, A., Amouzegar, A., Mehran, L., and Azizi, F., The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: A meta-analysis, Sci. Rep., 2023, vol. 13, no. 1, p. 18757.
Article CAS PubMed PubMed Central Google Scholar
Ali, S.E. and Khaleel, F.M., Assessing the activity of renin and GST in the serum of ladies suffering from polycystic ovary syndrome and COVID-19 to predict the danger of cardiac disease, Baghdad Sci. J., 2023, vol. 20, no. 3, pp. 0986–0993.
Silander, K.M., Pihlajamaa, P., Sahu, B., Jänne, O.A., and Andersson, L.C., Characterization of an androgen-responsive, ornithine decarboxylase-related protein in mouse kidney, Biosci. Rep., 2017, vol. 37, no. 4, p. BSR20170163.
Comments (0)